HeyJaredCristina Howorun
- Indexed articles, last 90 days
- 6
- Latest publication
- Aug 17, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 10, 2026
Latest articles
EXCLUSIVE: U.S. policy compelling some drug companies to stall medicine rollouts in Canada (opens the original)
Read excerpt
Nearly 50 life-extending, enriching or saving drugs have cancelled or delayed their Canadian launches in the past year; some of which, were already approved by Health Canada. “Canadians need to know that in the not-too-distant future, the cutting-edge medications that would help them with their rare disease may simply not be available to them,” says Dr. Michelle Hladunewich, a nephrologist and Physician-in-Chief at Sunnybrook Health Sciences. She points to U.S. President Trumps’ Most Favoured Na
EXCLUSIVE: Drug companies choosing not to sell life-saving and life-extending medicines in Canada (opens the original)
Read excerpt
When Ruchi Ambike found out that Novartis got Health Canada approval for Vanrafia she was ecstatic. The drug can possibly slow down the progression of her Immunoglobulin gA nephropathy, (IgAN) and ultimately, end-stage kidney disease. “It’s exciting because we have no IgAN drugs in Canada,” she says from her Mississauga home. IgAN is a rare autoimmune disorder affecting the kidneys, limiting their ability to filter waste properly. Some patients progress to end-stage kidney disease which means a
Toronto parents writing letters to TDSB supervisor urging a reversal of cost-cutting measures (opens the original)
Read excerpt
A group of Toronto parents are campaigning for more accountability from the provincially-appointed Toronto District School Board (TDSB) supervisor and through a letter-writing campaign in hopes of reversing some cost-cutting measures. The parents involved say some of the cuts are particularly deep at individual schools and will be deeply impacting the students. Each letter written reflects the “unique circumstances at each individual school community,” but the parents say they identify strikingl
Thousands of jobs, billions of dollars on the line in Brampton defence company's bid to expand (opens the original)
Read excerpt
Brampton-based armoured vehicle manufacturer Roshel has already outgrown its 400,000 square feet of manufacturing, research and development space. The decade-old company has become the go-to provider of Light Utility Vehicles (LUVs) to Ukraine and several NATO countries, including the U.S., Germany, the UK and France and is in serious contention to land a multi-billion-dollar deal with the federal government. But it needs space, about two million square feet. “We know that many automotive compan
Brampton-based Roshel in the mix as Canada narrows search for armoured vehicle fleet (opens the original)
Read excerpt
As Canada gears up to spend 2 per cent of its GDP on defence by the end of this fiscal year, it’s investing nearly $5 billion in a new fleet of armoured and unarmoured land utility vehicles. CityNews has learned only two bids remain on the table and one of them is local. Roshel has only been in operation for about a decade, but the Brampton-based armoured vehicle manufacturer has left its mark around the world. “Roshel produced over 2,500 vehicles for Ukraine alone, which made us the largest arm
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.